Paul Tudor Jones’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Paul Tudor Jones’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-14,839	Closed	-$108K	–	1292
2018 Q3	$108K	Hold	14,839	–	–	﹤0.01%	1020
2018 Q2	$55K	Hold	14,839	–	–	﹤0.01%	1001
2018 Q1	$57K	Hold	14,839	–	–	﹤0.01%	947
2017 Q4	$53K	Hold	14,839	–	–	﹤0.01%	1042
2017 Q3	$59K	Buy	14,839 +2,588	+21%	+$11.9K	﹤0.01%	1037
2017 Q2	$62K	Buy	12,251 +1,046	+9%	+$5.88K	﹤0.01%	976
2017 Q1	$77K	Sell	11,205 -3,329	-23%	-$26K	﹤0.01%	1322
2016 Q4	$136K	Buy	14,534 +2,480	+21%	+$22.3K	﹤0.01%	1281
2016 Q3	$118K	Buy	12,054 +893	+8%	+$12K	﹤0.01%	1324
2016 Q2	$158K	Sell	11,161 -1,732	-13%	-$27K	﹤0.01%	1455
2016 Q1	$180K	Buy	12,893 +1,143	+10%	+$16.8K	﹤0.01%	1527
2015 Q4	$240K	Buy	+11,750	New	+$181K	0.01%	1350
2015 Q3	–	Sell	-11,044	Closed	-$169K	–	1804
2015 Q2	$169K	Buy	+11,044	New	+$212K	﹤0.01%	1367

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Paul Tudor Jones's AGTC Position: Q4 2018 in Review

Paul Tudor Jones sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2018, closing a stake of 14,839 shares — an estimated $108K sold.

Paul Tudor Jones first reported a position in AGTC in Q2 2015 and held it in 13 quarters. The position peaked at $240K in Q4 2015. 54 funds tracked by Wall St. Rank hold AGTC as of Q4 2018.

Paul Tudor Jones reported no remaining Applied Genetic Technologies Corporation position as of Q4 2018 after selling out during the quarter.
Paul Tudor Jones sold 14,839 Applied Genetic Technologies Corporation shares in Q4 2018, an estimated $108K.
Paul Tudor Jones first reported a position in Applied Genetic Technologies Corporation in Q2 2015 and held it in 13 quarters.
Paul Tudor Jones's Applied Genetic Technologies Corporation position peaked at $240K in Q4 2015.
54 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2018.

Based on Tudor Investment Corp's 13F filing for Q4 2018, filed 14 Feb 2019.